
Ravdeep Singh Anand
About Ravdeep Singh Anand
Data last updated:
Ravdeep Singh Anand is a Director at Hanugen Therapeutics Private Limited (since 2017) and Director at Krm Ananda Ventures Private Limited (since 2025). The companies operate in Life Sciences. The largest current company by reported revenue is Hanugen Therapeutics Private Limited at ₹1.23 Cr (FY 2025). Earlier, Ravdeep Singh Anand was a Director at Genophe Biotech Private Limited (2018–2020) and Designated Partner at Rpr Solutions Llp (from 2010).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Feb 2017 | 2017 | ₹1.23 Cr (FY 2025) | Active | |
| Director | 23 Dec 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 05 Jan 2018 | 2018 | ₹44,240 (FY 2024) | Active | |
| Designated Partner | 04 Nov 2010 | 2010 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ravdeep Singh Anand
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arun Shastry | 07714115 | Hanugen Therapeutics Private Limited | Director |
| Manjulam | 07714144 | Hanugen Therapeutics Private Limited | Director |
| Movin Anand | 11446800 | Krm Ananda Ventures Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravdeep Singh Anand
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravdeep Singh Anand
Ravdeep Singh Anand currently holds 2 directorships: Hanugen Therapeutics Private Limited (Director, since 20 Feb 2017, revenue βΉ1.23 Cr (FY 2025)); Krm Ananda Ventures Private Limited (Director, since 23 Dec 2025).
Ravdeep Singh Anand was first appointed on 04 Nov 2010 as Designated Partner at Rpr Solutions Llp. The most recent appointment on record is 23 Dec 2025 at Krm Ananda Ventures Private Limited.
Ravdeep Singh Anand held 2 earlier board appointments: Genophe Biotech Private Limited (Director, 05 Jan 2018 to 13 Mar 2020); Rpr Solutions Llp (Designated Partner, from 04 Nov 2010).
The current boards of Ravdeep Singh Anand's companies include Arun Shastry (Hanugen Therapeutics Private Limited), Manjulam (Hanugen Therapeutics Private Limited), Movin Anand (Krm Ananda Ventures Private Limited).